THIS NEW HOPE FOR WEIGHT CONTROL ?

Scientists are rapidly investigating retatrutide, a novel drug from Eli Lilly, as a potential advance in body reduction . Unlike many earlier approaches, retatrutide is a dual -action agonist targeting both GLP-1 and GIP, substances that affect appetite and blood sugar control . Early clinical s